The Sarcoma Journal Author Guidelines
THE SARCOMA JOURNAL (TSJ), the official journal of the Sarcoma Foundation of America (curesarcoma.org), is a quarterly, peer-reviewed journal committed to:
- Meeting the information needs of oncologists as they pertain to sarcoma.
- Publishing original research reports, review and state-of-the-art papers, case reports, research letters, commentaries, letters to the editor, columns/features, and news articles related to the diagnosis and treatment of sarcomas.
- Exploring electronic publication to enhance and supplement dissemination of original research and evidence-based information to become a vital clinical forum and resource for oncologists.
Review and State-of-the-Art Papers
Manuscript Submission
We require electronic submission of manuscripts. Please submit your manuscript and tables as a Microsoft Word file attached to an e-mail to eriley@mdedge.com. We will confirm successful receipt of your manuscript by e-mail.
Cover Letter: The cover letter should include the name, address, telephone numbers, and e-mail address of the corresponding author. The letter should make it clear that the manuscript has not been published in another journal and is not under consideration by another journal, and that the final manuscript has been seen and approved by all authors.
Conflict of Interest: The authors should disclose in the cover letter any affiliations or financial arrangements with any company whose product appears prominently in the manuscript or with any company making a competing product. Such information will be kept in confidence while the paper is under review. If the article is accepted for publication, full disclosure will be required.
Third-party Support/Assistance: TSJ does not accept articles that have been developed by or written with financial support from a commercial entity (eg, pharmaceutical company or medical device manufacturer) or whose authors have received writing assistance from a commercially sponsored third party, such as a medical education company or a publication planner. Authors who have received such support or funding (and entities that have supported such articles) should contact fiorio@mdedge.com to explore opportunities to publish sponsored supplements to TSJ.
Original Research Exception. TSJ does accept original research articles in which the study was funded by a pharmaceutical company or in which the author(s) are employed by one, provided that all funding and affiliations are fully disclosed. Authors may not, however, receive any form of writing assistance. (See above).
The Peer Review Process: All TSJ articles undergo peer review to determine whether the submission meets the needs of TSJ readers and thus is suitable for publication.
Questions about this policy should be directed to eriley@mdedge.com
